Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody

Tuesday, February 1, 2022 1 min read

Key Takeaway: Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody

Full Press Release Details

Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody.